Every thing she presents cant be taken as definitive, it's a standard requirement of any presentation to start with a disclaimer so any progress chart with incoming milestones is always "stretchable", but when you set up to do an interview where most of the questions have already either been submitted to you in advance or - most probably - have actually been written down by you - then you have rehearsed your answers and what you say can be assumed to have been thought through. People tries to do their due diligence and relay on the indications given by a CEO, she rehearsed and thought through her answers in preparation of the interview so let's just hope that comes March the "early preliminary data" regarding "6 or 7 patients" receiving the oncarlytics treatment is announced. If not it'll be just another deja-vu moment brought to you by big mouth.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)